Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Elevated blood glucose is a consideration for patients with prediabetes or insulin resistance, and we monitor for this during treatment
However, the therapeutic management is extremely challenging, due to the diagnostic and ethical issues presented by many patients and the difficulty in providing a precise prognosis for any individual patient
It is even possible that the insulin-stimulating, glucagon-suppressing effects of the peptide or a more active synthetic analogue may be useful in the treatment of non-insulin-dependent diabetes, in which both impaired insulin release in response to glucose and persistent hyperglucagonemia are thought to be key pathophysiological abnormalities' (Kreymann, Ghattei, Williams, Bloom)
And it bypasses the first-pass effect that hurts oral bioavailability
US$ 21.23
US$ 27.32
US$ 20.02
US$ 25.42
US$ 29.60
US$ 26.28
US$ 24.04
